The WHO does not recommend GLP-1 receptor agonist drugs or bariatric surgery in children under 10 years of age with obesity
World2 sources2 countries🔦 Under-reported56m ago
The World Health Organization (WHO) has published its first international guidelines regarding childhood and adolescent obesity, announcing that it does not recommend the use of GLP-1 receptor agonist drugs or bariatric surgery for children under the age of 10 with obesity.
This policy response comes amid a significant global rise in childhood and adolescent obesity. According to the WHO data released with the guidelines, the prevalence of obesity among children and adolescents aged 5 to 19 has quadrupled globally since 1990, increasing from 2 percent to 8 percent.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Infobae (Buenos Aires, Argentina) (AR)Focuses specifically on the exclusion of drugs and surgery for young children.
Diario Libre (Santo Domingo, Dominican Republic) (DO)Emphasizes the global rise and quadrupling of childhood obesity rates.
Newz